Suppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumab

ChEBI2014-03-31 更新2026-07-21 收录

银屑病治疗

炎症生物标志物

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-55201 数据链接链接失效反馈

官方服务：

资源简介：

Suppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumab

创建时间：

2014-03-31

The Patient’s Guide to Psoriasis Treatment. Part 1: UVB Phototherapy

银屑病治疗

UVB光疗

Article full text The full text of this article can be found here . https://link.springer.com/article/10.1007/s13555-016-0129-2 The full text of all of the articles in this Topi

DataCite Commons2020-08-30 更新150

Predictors of Severity in Paradoxical Psoriasis from Biologic Therapies: A Systematic Review

银屑病治疗

生物疗法

Supplementary material Figure 1 - PRISMA flow diagram Table 1 - Multivariable meta-regression of paradoxical reactions for predictors of severity

DataCite Commons2025-05-01 更新70

银屑病治疗

药物疗效安全性

This record contains raw data related to article “Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian la

Zenodo2022-11-08 更新00

Supplementary Material for: Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and monocyte/lymphocyte ratio: A post hoc analysis of three randomised clinical trials

银屑病治疗

系统性炎症

Background Psoriasis is associated with an increased risk of cardiovascular disease (CVD). Previous studies have found that treatment with tumour necrosis factor or interleukin (IL)-17 inhibitors lead

DataCite Commons2025-06-01 更新80

Oral JAK Inhibitors in the Management of Nail Psoriasis: An Evidence Based Review

银屑病治疗

JAK抑制剂疗效

Nail psoriasis is a manifestation of psoriasis localized to the nails, often presenting with pitting, onycholysis, and subungual hyperkeratosis. Currently, there are no FDA approved treatments specifi

Mendeley Data50

Suppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumab

资源简介：

相关数据集